Pictura Bio is a University of Oxford spin-out (founded 2022, formerly OxDX) building one-minute infectious-disease diagnostics. Its platform pairs a universal fluorescent labelling reagent (PIC-ID) with the benchtop VISTA fluorescence reader and deep-learning image analysis to identify pathogens and their strains directly in clinical samples, replacing pathogen-specific test panels with a single reagent and software-updatable detection. The company runs the ResVir respiratory clinical study with NHS Portsmouth's Queen Alexandra Hospital, delivered a ruggedized prototype under a UK Ministry of Defence DASA contract, and is backed by IQ Capital, Ahren Innovation Capital and Science Creates Ventures.
1
Round
1
Industry
5
Tags
Sep 28, 2026
Latest raise
Funding activity · 1 round
Sep 28, 2026
$9.1M
Series A
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
